The short version of Heptapeptide fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-06-01. Anything still debated is marked as such rather than presented as settled.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
Reported observations after unregulated use include shifts in skin pigmentation and, in some accounts, unintended changes to moles and other lesions. Whether these outcomes are causally linked to the compound, and how often they occur, remain open questions because controlled data are scarce. The absence of standardised dosing and verified product purity complicates interpretation. Researchers have called for better surveillance and analytical characterisation of samples obtained outside regulated channels. Conclusions drawn from anecdotal evidence should be treated as provisional.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Unapproved for therapeutic use | No marketing authorisation from major agencies |
| Legal classification | Varies by jurisdiction | Prescription-only or controlled in several countries |
| Common synonyms | Melanotan II; MT-II | Also referenced by catalogue codes |
| Typical analytical method | Reverse-phase HPLC | Often paired with mass spectrometry |
| Primary literature focus | Receptor pharmacology | Pigmentation and melanocortin signalling |
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
=== Starting stage === Loading: The first amino acid is activated with ATP as a mixed acyl-phosphoric acid anhydride with AMP by the A-domain and loaded onto the serine-attached 4'-phospho-pantethine (4'PP) sidechain of the PCP-domain catalyzed by the PCP-domain (thiolation). Some A domains require interaction with MbtH-like proteins for their activity. Sometimes the amino group of the bound amino acid is formylated by an F-domain or methylated by an NMT-domain.
Redness of the sclera is typically caused by eye irritation causing blood vessels to expand, such as in conjunctivitis ("pink eye"). Episcleritis is a generally benign condition of the episclera causing eye redness. Scleritis is a serious inflammatory disease of the sclera causing redness of the sclera often progressing to purple. Yellowing or a light green color of the sclera is a visual symptom of jaundice. In cases of osteogenesis imperfecta, the sclera may appear to have a blue tint, more pronounced than the slight blue tint seen in children. The blue tint is caused by the showing of the underlying uveal tract (choroid and retinal pigment epithelium). In those with Ehlers–Danlos syndrome, the sclera may be tinted blue due to the lack of proper connective tissue. In very rare but severe cases of kidney failure and liver failure, the sclera may turn black. Early reports of white sclera in chimpanzees have been reported as possibly pathological and considered anomalies. Though this assumption is a good starting point in creating a foundation for what we know about sclera in animals, sources have experienced challenges acquiring large sample sizes in order to come up with conclusive evidence to support these claims fully.
== Biology == SNO-Cap (S-Nitrosocaptopril), a nitrovasodilator Snowcap, a large white area of coloration in horses from the coat patterns of the leopard complex snow-capped manakin (Lepidothrix nattereri), a bird snowcap (Microchera albocoronata), a hummingbird Snowcap, a Sativa-dominant hybrid strain of marijuana, see List of names for cannabis strains
Sources: en.wikipedia.org
Le Havre appears in several literary works as a point of departure to America: in the 18th century, Father Prevost embarked Manon Lescaut and Des Grieux for French Louisiana. Fanny Loviot departed from Le Havre in 1852, as an emigrant to San Francisco and points further west, and recounted her adventures in Les pirates chinois (A Lady's Captivity among Chinese Pirates in the Chinese Seas, 1858). In the 19th century, Le Havre was the setting for several French novels: Honoré de Balzac described the failure of a Le Havre merchant family in Modeste Mignon. Later, the Norman writer Guy de Maupassant located several of his works at Le Havre such as Au muséum d'histoire naturelle (At the Museum of Natural History) a text published in Le Gaulois on 23 March 1881 and again in Pierre et Jean. Alphonse Allais located his intrigues at Le Havre too. La Bête humaine (The Human Beast) by Émile Zola evokes the world of the railway and runs along the Paris–Le Havre railway. Streets, buildings, and public places in Le Havre pay tribute to other famous Le Havre people from this period: the writer Casimir Delavigne (1793–1843) has a street named after him and a statue in front of the palace of justice alongside another man of letters, Bernardin de Saint-Pierre (1737–1814). In the 20th century, Henry Miller located part of the action in Le Havre in his masterpiece Tropic of Cancer, published in 1934. Bouville was the commune where the writer lived who wrote his diary in La Nausée (The Nausea) (1938) by Jean-Paul Sartre who was inspired by Le Havre city where he wrote his first novel.
== Application == B1H system provides a tool in our arsenal for identifying the DNA-binding specificities of transcription factors and thus predicting their target genes and genomic DNA regulatory elements. It also allows for examination of the effects of protein–protein interactions on DNA binding, which may further guide the prediction of cis regulatory modules based on binding-site clustering. Moreover, the B1H selection system has implications for the predicting regulatory roles of previously uncharacterized transcription factors.
=== Prevalence in rain, soil, water bodies, and air === In 2022, levels of at least four perfluoroalkyl acids (PFAAs) in rain water worldwide greatly exceeded the EPA's lifetime drinking water health advisories as well as comparable Danish, Dutch, and European Union safety standards, leading to the conclusion that "the global spread of these four PFAAs in the atmosphere has led to the planetary boundary for chemical pollution being exceeded". The most common PFAS found in the environment is Trifluoroacetic acid (TFA). Its presence is ubiquitous in the environment, especially in aquatic ecosystems, where it persists with increasing concentrations globally. It had been thought that PFAAs would eventually end up in the oceans, where they would be diluted over decades, but a field study published in 2021 by researchers at Stockholm University found that they are often transferred from water to air when waves reach land, are a significant source of air pollution, and eventually get into rain. The researchers concluded that pollution may impact large areas. Soil is also contaminated and the chemicals have been found in remote areas such as Antarctica. Soil contamination can result in higher levels of PFAS found in foods such as white rice, coffee, and animals reared on contaminated ground. In 2024, a worldwide study of 45,000 groundwater samples found that 31% of samples contained levels of PFAS that were harmful to human health; these samples were taken from areas not near any obvious source of contamination.
Russia launched an offensive in Kharkiv Oblast, pushing Ukrainian forces back one kilometer from the international border. Heavy shelling was reported in Vovchansk. Five villages (Strilecha, Krasne, Pylna, Borysivka and Ohirtseve) were reported to have been taken by Russia, while fighting was ongoing in the villages of Pletenivka and Hatyshche. At least two civilians were killed in Russian attacks. During a press conference with Slovak President Zuzana Čaputová, Zelenskyy acknowledged the Russian offensive, but said that "Ukraine met them there with our troops, brigades, and artillery." One person was killed by Russian shelling in Sumy Oblast. Two people were killed in separate Russian attacks in Donetsk Oblast. Russian-installed officials in Luhansk Oblast claimed that three people were killed and seven others injured in a drone strike on the Rovenky oil depot. Ukrainian media reported that the HUR carried out a drone strike on an oil refinery in Russia's Kaluga Oblast. Russian officials also claimed that drone strikes caused damage in Belgorod and Kursk Oblasts. The Czech Republic delivered an F-16 fighter jet simulator to Ukraine.
Sources: en.wikipedia.org
== Solid phase peptide synthesis == The established method for the production of synthetic peptides is known as solid phase peptide synthesis (SPPS). Pioneered by Robert Bruce Merrifield, SPPS allows facile assembly of a target peptide by stepwise addition of amino acids while the growing peptide chain is attached to a macroscopically insoluble solvent-swollen beaded resin support.
Another Tyrannosaurus, nicknamed Stan (NHMAD 2020.00001, formerly BHI 3033), in honor of amateur paleontologist Stan Sacrison, was recovered from the Hell Creek Formation in 1992. Stan is the second most complete skeleton found, with 199 bones recovered representing 70% of the total. This tyrannosaur also had many bone pathologies, including broken and healed ribs, a broken and healed neck, and a substantial hole in the back of its head, about the size of a Tyrannosaurus tooth. In 1998, 20-year-old Bucky Derflinger noticed a T. rex toe exposed above ground, making him the youngest person to discover a Tyrannosaurus. The specimen, dubbed Bucky in honor of its discoverer, was a young adult, 3.0 metres (10 ft) tall and 11 metres (35 ft) long. Bucky is the first Tyrannosaurus to be found that preserved a furcula (wishbone). Bucky is permanently displayed at The Children's Museum of Indianapolis.
"Osteogenesis Imperfecta Overview". NIH Osteoporosis and Related Bone Diseases. National Resource Center, National Institutes of Health, U.S. Department of Health and Human Services. 8 May 2023. Archived from the original on 4 October 2017.
Sources: en.wikipedia.org
Major regulatory agencies have not approved it for any indication. Some countries permit it only under prescription frameworks, while others classify it as a controlled substance.
Much of the evidence comes from case reports and accounts of unregulated use rather than controlled trials. Differences in product purity and dosing add further variability.
Laboratory work focuses on receptor binding and cellular signalling. Observational reports document outcomes after use, and analytical chemists examine samples to assess content and purity.
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.